Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer


Tara N. Fujimoto
May 1, 2019; 79:2327-2338
Adjuvant Endocrine Therapy

Powered by WPeMatico

Leave a Reply